CliffBio
small molecule

CEFTAZIDIME SODIUM IN PLASTIC CONTAINER

CEFTAZIDIME SODIUM

Loss of exclusivity—loss of exclusivity
CompanyBaxter Healthcare Corp →See this company's full patent-cliff portfolio

Drug detail

Brand nameCEFTAZIDIME SODIUM IN PLASTIC CONTAINER
Active ingredientCEFTAZIDIME SODIUM
StrengthEQ 10MG BASE/ML
Dosage formINJECTABLE
RouteINJECTION
ModalitySmall molecule
FDA approvalApril 1993
Marketing statusDISCN

More from Baxter Healthcare Corp

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the loss of exclusivity; estimates are projections, not legal advice.